Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Barbiturate withdrawal--a nomogram for supplementary dosing after the phenobarbitone loading technique.

N A Buckley1, A Foy

  • 1Discipline of Clinical Pharmacology, University of Newcastle, New South Wales, Australia.

Drug and Alcohol Review
|January 1, 1995
PubMed
Summary

Barbiturate withdrawal can be serious, causing seizures and delirium. A new nomogram helps determine necessary supplementary phenobarbitone doses to manage this syndrome effectively.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sex/gender differences in clinical pharmacology: A perspective from the IUPHAR World Smart Medication Day 2025.

Pharmacological research·2025
Same author

Comment on: "population pharmacokinetic analysis of acetaminophen overdose with immediate release, extended release and modified release formulations".

Clinical toxicology (Philadelphia, Pa.)·2022
Same author

Deliberate self-poisoning in Australian adolescents is increased on school days.

Journal of psychiatric research·2022
Same author

Acute alcohol use in Australian coronial suicide cases, 2010-2015.

Drug and alcohol dependence·2020
Same author

Effect of age on the severity of chronic lithium poisoning.

Clinical toxicology (Philadelphia, Pa.)·2020
Same author

A randomized controlled trial of fresh frozen plasma for coagulopathy in Russell's viper (Daboia russelii) envenoming.

Journal of thrombosis and haemostasis : JTH·2017

Area of Science:

  • Pharmacology
  • Clinical Toxicology
  • Neurology

Background:

  • Barbiturate withdrawal syndrome presents significant clinical challenges, including seizures and delirium.
  • Phenobarbitone, a barbiturate, has a short elimination half-life, necessitating careful dose management during withdrawal.
  • Managing barbiturate withdrawal requires precise dosing to prevent severe complications.

Purpose of the Study:

  • To describe a case highlighting the severity of barbiturate withdrawal syndrome.
  • To introduce a novel nomogram for guiding phenobarbitone dosing during withdrawal.
  • To facilitate rapid and accurate determination of supplementary phenobarbitone requirements.

Main Methods:

  • Case presentation of a patient with multiple drug overdose and subsequent barbiturate withdrawal.

Related Experiment Videos

  • Utilized serum phenobarbitone levels in conjunction with a newly devised nomogram.
  • Employed supplementary phenobarbitone doses for prevention and treatment of withdrawal complications.

    • Main Results:

    • The patient experienced a severe barbiturate withdrawal syndrome complicated by seizures and delirium.
    • The short elimination half-life of phenobarbitone complicated management.
    • The nomogram, combined with serum levels, enabled effective determination of supplementary phenobarbitone doses.

    Conclusions:

    • Barbiturate withdrawal syndrome is a serious condition requiring vigilant management.
    • The devised nomogram offers a practical tool for optimizing phenobarbitone dosing during withdrawal.
    • This approach aids in preventing and treating severe withdrawal complications like seizures and delirium.